BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2017
View Archived Issues
Brickell Biotech reports results of confirmatory phase IIb study of sofpironium bromide
Read More
FDA orphan drug status granted to Synlogic's SYNB-1618
Read More
FDA awards orphan drug status to Zealand Pharma's glepaglutide
Read More
Momelotinib does not appear to add to erlotinib benefit in NSCLC trial
Read More
Catalyst Biosciences and Mosaic Biosciences to develop anti-C3 protease compounds
Read More
New candidate prodrug TransCon CNP for treating achondroplasia shows promise
Read More
Novel PET tracer 68Ga-NOTA-3PTATE-RGD shows promise for imaging lung cancer, neuroendocrine tumors
Read More
Alector and AbbVie enter global collaboration to advance novel immune-neurology candidates
Read More
Pain Therapeutics completes phase I study of Alzheimer's candidate
Read More
Imprimis Pharmaceuticals launches subsidiary
Read More
Safety and immunological data presented for TG-1050 for HBV infection
Read More
Minneamrita commences phase I testing of oral minnelide in advanced cancer
Read More
Novartis reflects on key milestones of third quarter 2017
Read More
Bispecific antibody ALG.APV-527 targets tumor antigen 5T4
Read More
MJFF and Tau Consortium fund development of novel PET imaging tracers for neurodegenerative diseases
Read More
RespiVert and Topivert Pharma patent kinase inhibitors
Read More
Pfizer's glasdegib given orphan drug designation for MDS
Read More
Ruzasvir/uprifosbuvir combination highly effective in genotypes 1, 2 and 4 HCV infection
Read More
Pulmocide divulges novel RSV fusion inhibitors
Read More
Alzheon's ALZ-801 awarded fast track designation from FDA
Read More
Collaboration to support Amylyx Pharmaceuticals's phase II study of AMX-0035
Read More
Immunocore presents constructs for treating HIV infection and AIDS
Read More
FDA grants fast track designation to MIV-711 for treatment of osteoarthritis
Read More
TVGV-HB vaccine shows promise in HBV mouse model
Read More